Rare Diseases and COVID-19: How are the Patients?


  • Hercílio Martelli-Júnior
  • Renato Assis Machado
  • Aluísio Eustáquio de Freitas Miranda Filho
  • Juliana de Lima Gonçalves
  • Mário Sérgio Oliveira Swerts


Dear Editor,

When searching the scientific literature COVID-19-associated syndromes in addition to syndromes middle eastern respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), some cardiovascular syndromes and post intensive care syndrome [1,2], we found the syndromes of Guillain-Barré, Miller Fisher, polyneuritis cranialis, Kawasaki, Inflammatory multisystem syndrome, and syndrome of inappropriate antidiuretic hormone secretion [3-29]. Of these, only Guillain-Barré syndrome and Miller Fisher syndrome, Kawasaki diseases and Inflammatory multisystem syndrome have currently present cranio-facial manifestation (Table 1), but possibly others will become know when the damage of COVID-19 becomes known.
Although there is no standardized definition of rare diseases, the classification of rare diseases is closely related to a definition according to point prevalence in the current political and legislative context, and such definitions are based on a prevalence threshold directly or implied. According to the World Health Organization (WOS) and adopted by the Ministry of Health of Brazil, a rare disease affects up to 65 per 100,000 individuals [30]. Each rare disease, taken separately, affects a limited number of people. Considering, however, that there are up to 8,000 types of rare diseases worldwide, when grouped under a single category, their epidemiological impact may become quite significant. About 80% of those are caused by genetic factors, and the rest by other factors, such as environmental, infectious and immunologicalones [31]. Thus, rare diseases are a global challenge that must be overcome. A multi-professional and interdisciplinary team, including pediatric dentistry, oral medicine and pathology, is essential for success throughout the process.


Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 2020; 141(23):1903-14. https://doi.org/10.1161/CIRCULATIONAHA.120.047349

Stam HJ, Stucki G, Bickenbach J. Covid-19 and Post Intensive Care Syndrome: A Call for Action. J Rehabil Med 2020; 52(4):jrm00044. https://doi.org/10.2340/16501977-2677

Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID-19 - associated Guillain-Barre Syndrome: the early pandemic experience. Muscle & Nerve 2020; 62(4):485-91. https://doi.org/10.1002/mus.27024

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki Disease: Novel virus and novel case. Hosp Pediatr 2020; 10(6):537-40. https://doi.org/10.1542/hpeds.2020-0123

Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol 2020; 34(10):e539-e541. https://doi.org/10.1111/jdv.16666

Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020; 369:m2094. https://doi.org/10.1136/bmj.m2094

Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324(3):259-69. https://doi.org/10.1001/jama.2020.10369

Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, Angoulvant F, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 2020; 25(22):2001010. https://doi.org/10.2807/1560-7917.ES.2020.25.22.2001010

Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L, et al. Characteristics, cardiac involvement, and outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) associated with SARS-CoV-2 Infection. J Pediatr 2020; 224:141-5. https://doi.org/10.1016/j.jpeds.2020.06.044

Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 2020; 324(3):294-6. https://doi.org/10.1001/jama.2020.10374

Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020; 9(3):393-8. https://doi.org/10.1093/jpids/piaa069

Dasgupta K, Finch SE. A Case of pediatric multisystem inflammatory syndrome temporally associated with COVID-19 in South Dakota. S D Med 2020; 73(6):246-51.

Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet 2020; 4(9):669-77. https://doi.org/10.1016/S2352-4642(20)30215-7

Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020; 383(4):347-58. https://doi.org/10.1056/NEJMoa2021756

Greene AG, Saleh M, Roseman E, Sinert R. Toxic shock-like syndrome and COVID-19: A case report of multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med 2020; S0735-6757(20)30492-7. https://doi.org/10.1016/j.ajem.2020.05.117

Lee PY, Day-Lewis M, Henderson LA, Friedman K, Lo J, Roberts JE, et al. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. J Clin Invest 2020; 141113. https://doi.org/10.1172/JCI141113

Perez-Toledo M, Faustini SE, Jossi SE, Shields AM, Kanthimathinathan HK, Allen JD, et al. Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome. medRxiv Preprint. 2020. https://doi.org/10.1101/2020.06.05.20123117

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, et al., Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 2020; 79(8):999-1006. https://doi.org/10.1136/annrheumdis-2020-217960

Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, et al. Paediatric Inflammatory Multisystem Syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 2020; 1-11. https://doi.org/10.1007/s00246-020-02391-2

Regev T, Antebi M, Eytan D, Shachor-Meyouhas Y, Ilivitzki A, Aviel YB, et al. Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following SARS-COV-2 infection. Pediatr Infect Dis J 2020; 39(8):e206-e207. https://doi.org/10.1097/INF.0000000000002804

Rivera-Figueroa EI, Santos R, Simpson S, Garg P. Incomplete Kawasaki disease in a child with Covid-19. Indian Pediatr 2020; 57(7):680-1. https://doi.org/10.1007/s13312-020-1900-0

Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Rosada R, Sordillo EM, et al. Multisystem Inflammatory Syndrome in Children (MIS-C) related to COVID-19: A New York City experience. J Med Virol 2020. https://doi.org/10.1002/jmv.26224.

Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med 2020. https://doi.org/10.1016/j.ajem.2020.06.053.

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395(10239):1771-8. https://doi.org/10.1016/S0140-6736(20)31103-X

Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, Pedro-Murillo ES, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology 2020; 95(5):e601-e605. https://doi.org/10.1212/WNL.0000000000009619

Fernández-Domínguez J, Ameijide-Sanluis E, García-Cabo C, García-Rodríguez R, Mateos V. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol 2020. https://doi.org/10.1007/s00415-020-09912-2

Lantos JE, Strauss SB, Lin E. COVID-19 – Associated Miller Fisher Syndrome: MRI findings. AJNR Am J Neuroradiol 2020; 41(7):1184-6. https://doi.org/10.3174/ajnr.A6609

Reyes-Bueno JA, García-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Martínez-Tomás C, et al. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol 2020. https://doi.org/10.1111/ene.14383

Yousaf Z, Al-Shokri SD, Al-soub H, Mohamed MFH. COVID-19-associated SIADH: a clue in the times of pandemic! Am J Physiol Endocrinol Metab 2020; 318(6):E882-E885. https://doi.org/10.1152/ajpendo.00178.2020

Martelli DRB, Martelli Júnior H. Undiagnosed and rare diseases: current challenges, perspectives and contribution of oral cavity examination. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 130(2):227-8. https://doi.org/10.1016/j.oooo.2020.04.011

Ramalle-Gómara E, Ruiz E, Quinones C, Andres S, Iruzubieta J, Gil-de-Gómez J. General knowledge and opinion of future health care and non-health care professionals on rare diseases. J Eval Clin Pract 2015; 21(2):198-201. https://doi.org/10.1111/jep.12281

Wakap SN, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet 2020; 28:165-73. https://doi.org/10.1038/s41431-019-0508-0

Brizola E, Adami G, Baroncelli GI, Bedeschi MF, Berardi P, Boero S, et al. Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic. Orphanet J Rare Dis 2020; 15(1):228. https://doi.org/10.1186/s13023-020-01513-6

Fiumara A, Lanzafame G, Arena A, Sapuppo A, Raudino F, Pratico A, et al. COVID-19 Pandemic Outbreak and its psychological impact on patients with rare lysosomal diseases. J Clin Med 2020; 9(9):E2716. https://doi.org/10.3390/jcm9092716

Costamagna G, Abati E, Bresolin N, Comi GP, Corti S. Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic. J Neurol 2020; 1-12. https://doi.org/10.1007/s00415-020-10149-2




How to Cite

Martelli-Júnior, H. ., Machado, R. A. ., Miranda Filho, A. E. de F. ., Gonçalves, J. de L., & Swerts, M. S. O. . (2021). Rare Diseases and COVID-19: How are the Patients?. Pesquisa Brasileira Em Odontopediatria E Clínica Integrada, 21, e0172. Retrieved from https://revista.uepb.edu.br/PBOCI/article/view/750



Letters to the Editor